Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement

IntroductionNational regulatory medicines authorities (NRAs) are mandated to ensure timely access to high-quality, safe and efficacious medical products, primarily achieved through a marketing authorisation procedure established in each country. The aim of this study which was similar to that carrie...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Mercy Owusu-Asante, Delese Mimi Darko, Seth Seaneke, Aminata Nacoulma, Oula Ibrahim Olivier Traore, Mojisola Christianah Adeyeye, Abayomi Akinyemi, Coulibaly Assane, Clarisse Épse Kaul Meledje Clamoungou, Oumy Kalsoum Ndao, Rokhaya Ndiaye Kande, James Komeh, Sheku Mansaray, Dalkoi Lamboni, Maheza Agba, Sam Salek, Stuart Walker
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2025-07-01
Seri Bilgileri:	Frontiers in Medicine
Konular:	African Medicines Agency (AMA) Economic Community of West African States Medicines Regulatory Harmonisation (ECOWAS-MRH) generics good review practices new active substances regulatory reliance
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1587761/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement

Benzer Materyaller